Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 195

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 195
---
ments, as of September 30, 2024 for the unaudited pro forma condensed combined balance sheet, for the nine months ended September
30, 2024 for the unaudited pro forma condensed combined statement of operations and the year ended December 31, 2023 for the unaudited
pro forma condensed combined statement of operations, are as follows:

Target Acquisitions Balance Sheet Pro Forma Adjustments

| (A) | Promissory notes due to FutureTech Capital LLC (“FutureTech Capital”) included in Notes payable 
 — related Party of Longevity convert into Longevity common stock as follows:                    |

(i) in
exchange for the first $6.215 million of principal amount of notes outstanding, that number of shares of Longevity common stock equal
to 20% of the total number of shares of Longevity common stock to be outstanding immediately prior to the Merger Effective Time, plus

(ii) in
exchange for each additional $750,000 of principal amount of notes outstanding, that number of shares of Longevity common stock equal
to an additional 1% of Longevity common stock outstanding immediately prior to the Merger Effective Time.

Promissory notes issued after September
30, 2024 included in the pro forma adjustments:

●$108,000 issued on October 31,
2024

●$75,000 issued on November 4,
2024

●$100,000 issued on November
15, 2024

●$100,000 issued on November
20, 2024

●$50,000 issued on December 13,
2024

●$100,000 issued on January 8,
2025

●$100,000 issued on January 27,
2025

These additional promissory notes
are captured in the Other Adjustments.

At the time of
the Target Acquisitions FutureTech Capital will be issued approximately 2,126,000 shares of common stock at a value of $10 per share.
$213 was recorded to common stock for the par value at $0.0001 per share and $8,903,206 was recorded to additional paid-in capital.

| (B) | To reflect the adjustments associated with the Aegeria asset acquisition as follows: |

| Elimination of historical common units                              |     | $ |    (144,897 | ) |
| Par value for the issuance of Longevity common stock                |     |   |         384 |   |
| Conversion of